238 related articles for article (PubMed ID: 10673237)
1. Functional studies of leukotriene receptors in vascular tissues.
Walch L; Norel X; Gascard JP; Brink C
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S107-11. PubMed ID: 10673237
[TBL] [Abstract][Full Text] [Related]
2. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
3. Cysteinyl-leukotriene receptors in pulmonary vessels.
Walch L; Norel X; Gascard JP; Brink C
J Physiol Pharmacol; 1999 Dec; 50(4):567-73. PubMed ID: 10639007
[TBL] [Abstract][Full Text] [Related]
4. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone.
Norel X; Walch L; Gascard JP; deMontpreville V; Brink C
Br J Pharmacol; 2004 Jun; 142(4):788-96. PubMed ID: 15172959
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
[TBL] [Abstract][Full Text] [Related]
7. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
Bäck M
Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of receptors for cysteinyl-leukotrienes in sheep trachealis muscle.
Jonsson EW
Pulm Pharmacol Ther; 1997; 10(1):29-36. PubMed ID: 9344830
[TBL] [Abstract][Full Text] [Related]
10. Functional characteristics of cysteinyl-leukotriene receptor subtypes.
Bäck M
Life Sci; 2002 Jun; 71(6):611-22. PubMed ID: 12072150
[TBL] [Abstract][Full Text] [Related]
11. 15-lipoxygenase metabolites of arachidonic acid evoke contractions and relaxations in isolated canine arteries: role of thromboxane receptors, endothelial cells and cyclooxygenase.
Van Diest MJ; Verbeuren TJ; Herman AG
J Pharmacol Exp Ther; 1991 Jan; 256(1):194-203. PubMed ID: 1824864
[TBL] [Abstract][Full Text] [Related]
12. A second cysteinyl leukotriene receptor in human lung.
Labat C; Ortiz JL; Norel X; Gorenne I; Verley J; Abram TS; Cuthbert NJ; Tudhope SR; Norman P; Gardiner P
J Pharmacol Exp Ther; 1992 Nov; 263(2):800-5. PubMed ID: 1331415
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene receptors on human pulmonary vascular endothelium.
Ortiz JL; Gorenne I; Cortijo J; Seller A; Labat C; Sarria B; Abram TS; Gardiner PJ; Morcillo E; Brink C
Br J Pharmacol; 1995 Aug; 115(8):1382-6. PubMed ID: 8564195
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
[TBL] [Abstract][Full Text] [Related]
15. The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues.
Norel X; Brink C
Pharmacol Ther; 2004 Jul; 103(1):81-94. PubMed ID: 15251228
[TBL] [Abstract][Full Text] [Related]
16. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism.
Pedersen KE; Bochner BS; Undem BJ
J Pharmacol Exp Ther; 1997 May; 281(2):655-62. PubMed ID: 9152370
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes.
Bäck M; Norel X; Walch L; Gascard J; de Montpreville V; Dahlén S; Brink C
Eur J Pharmacol; 2000 Aug; 401(3):389-95. PubMed ID: 10936498
[TBL] [Abstract][Full Text] [Related]
18. Modulation of vascular tone and reactivity by nitric oxide in porcine pulmonary arteries and veins.
Bäck M; Walch L; Norel X; Gascard JP; Mazmanian G; Brink C
Acta Physiol Scand; 2002 Jan; 174(1):9-15. PubMed ID: 11851592
[TBL] [Abstract][Full Text] [Related]
19. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cysteinyl leukotriene receptors on human saphenous veins: antagonist activity of montelukast and its metabolites.
Mechiche H; Candenas L; Pinto FM; Nazeyrollas P; Clément C; Devillier P
J Cardiovasc Pharmacol; 2004 Jan; 43(1):113-20. PubMed ID: 14668576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
